Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/126672
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Meta-analysis of prevalence and risk factors for cognitive decline and improvement after transcatheter aortic valve implantation |
Author: | Ghezzi, E.S. Ross, T.J. Davis, D. Psaltis, P.J. Loetscher, T. Keage, H.A.D. |
Citation: | American Journal of Cardiology, 2020; 127:105-112 |
Publisher: | Elsevier |
Issue Date: | 2020 |
ISSN: | 0002-9149 1879-1913 |
Statement of Responsibility: | Erica S.Ghezzi, Tyler J.Ross, Daniel Davis, Peter J.Psaltis, Tobias Loetscher, Hannah A.D.Keage |
Abstract: | Changes to cognition, both decline and improvement, are commonly reported after transcatheter aortic valve implantation (TAVI). However, previous systematic reviews and meta-analyses have missed these subgroups by assessing whole-group-averages for cognitive outcomes. We sought to pool estimates to identify the prevalence of cognitive decline and improvement after TAVI, as well as associated factors for these outcomes. A systematic review identified 15 articles appropriate for meta-analysis. When robust cognitive change definitions were employed, the pooled prevalence of incident cognitive impairment up to 1-, 1 to 6-, and ≥6-months post-TAVI was 7%, 14%, and 12%, respectively. For cognitive improvement, the prevalence from 1 to 6 months and ≥6 months after TAVI was estimated to be 19% and 11%, respectively. Two factors were associated with these cognitive outcomes: (1) using a cerebral embolic protection device was associated with decreased prevalence of cognitive decline up to 1-week post-TAVI; (2) baseline cognitive impairment had a large association with post-TAVI cognitive improvement. In conclusion, cognitive decline and cognitive improvement are experienced by approximately 7% to 19% of patients after TAVI, respectively. Those with the lowest cognitive performance pre-TAVI appear to have the most to gain in terms of cognitive improvement post-TAVI. Identifying further predictive factors for cognitive decline and improvement post-TAVI will facilitate a personalized-medicine approach for cognitive care and prognosis. |
Keywords: | Humans Aortic Valve Stenosis Postoperative Complications Prevalence Risk Factors Cognition Recovery of Function Global Health Transcatheter Aortic Valve Replacement Cognitive Dysfunction |
Rights: | © 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license |
DOI: | 10.1016/j.amjcard.2020.04.023 |
Published version: | http://dx.doi.org/10.1016/j.amjcard.2020.04.023 |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_126672.pdf | Published version | 198.16 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.